“Adverse events from the Pfizer-BioNTech® COVID-19 vaccine in children 5-17 years old”, Rev Alerg Mex, vol. 71, no. 3, pp. 139–145, Dec. 2024, doi: 10.29262/ram.v71i3.1316.